MarketPeel
Insider Trading Intelligence
SO

Steven J. O'day

AGEN
CHIEF MEDICAL OFFICER · AGENUS INC · CIK 0001845281
FILING MIX · LIFETIME85%/15%
BUYS
11
SELLS
2
TOTAL VALUE
$836.0K
COMPANIES
1
ACTIVE SINCE
Jan 2022
HOLDINGS NOW
95,333
AVG SELL PX
$3.06
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Steven J. O'day, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-5.86%-0.73%-5.13%-5.13%
14d1+100.00%-10.75%-4.53%-6.22%-6.22%
30d1+100.00%-22.15%-4.11%-18.04%-18.04%
60d1+100.00%-4.89%-10.37%+5.48%+5.48%
90d1+100.00%-15.96%-4.28%-11.68%-11.68%
180d1+100.00%-21.50%-17.77%-3.73%-3.73%
1y1+100.00%-21.82%-15.72%-6.11%-6.11%
2y1+100.00%-74.64%+3.17%-77.80%-77.80%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AGEN · 95,333 shares · as of Apr 24, 2026
068,096136,192204,288272,3842023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 2 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
70,00070,000Apr 24, 2026Apr 28, 2026View →
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
95,33395,333Apr 24, 2026Apr 28, 2026View →
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
43,497$4.47$194.4K57,116Jun 18, 2025Jun 30, 2025View →
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
50,00050,000Nov 14, 2024Nov 18, 2024View →
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
37,90737,907Jun 11, 2024Jun 18, 2024View →
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
10,00010,000Jun 11, 2024Jun 18, 2024View →
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
109,381$2.45$268.0K272,384Jan 5, 2023Jan 9, 2023View →
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
200,000200,000Jan 5, 2023Jan 9, 2023View →
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
101,682$2.51$255.2K163,003Feb 2, 2022Feb 4, 2022View →
AGEN
AGENUS INC
SALE
Chief Medical Officer
38,679$3.06$118.3K61,321Jan 6, 2022Jan 6, 2022View →
AGEN
AGENUS INC
PURCHASE
Chief Medical Officer
100,000100,000Jan 4, 2022Jan 6, 2022View →
AGEN
AGENUS INC
SALE
Chief Medical Officer
100,0000Jan 4, 2022Jan 6, 2022View →
AGEN
AGENUS INC
PURCHASEGRANT
Stock grant
150,000150,000Jan 2, 2022Jan 4, 2022View →
Other insiders · AGEN
Loading peer insiders…
About this filer
CIK 0001845281
ROLE
Chief Medical Officer
PRIMARY
AGEN
COMPANIES
1
ACTIVE SINCE
Jan 2022
MARKETPEEL · /INSIDER/0001845281DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback